YIMI logo

YIMI

Asia, Guangdong, China, Guangzhou

Description

YIMI is a private equity fund management firm.

Investor Profile

YIMI has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Manufacturing
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does YIMI frequently co-invest with?

Guangdong Technology Financial Group
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 1
Wanlian Tianze
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
GK
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
PI
Asia, Guangdong, China, Panyu
Co-Investments: 1
Co-Investments: 1
Chuangyu Investment Management
Asia, Guangdong, China, Huangpu
Co-Investments: 1
BOC & Utrust Private Equity Fund Management
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
KC
Asia, Guangdong, China, Guangzhou
Co-Investments: 1

What are some of recent deals done by YIMI?

Bostal Drug Delivery

Guangzhou, Guangdong, China

Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems.

BiotechnologyHealth CareLife ScienceManufacturingPharmaceutical
Series BAug 19, 2023